Connolly RM, Wang V, Hyman DM, Grivas P, et al. Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clin Cancer Res 2024;30:1273-1280.
PMID: 38433347